Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: The anti-tumor and renoprotection study of E-[c(RGDfK)2]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid A

Fig. 2

Fluorescent photos and the bar graphs of fluorescence intensity of four tumor cells treated with different preparations after 8 h. Fluorescence picture (a) and intensity (c) of 4T1 cells, fluorescence picture (b) and intensity (d) of MDA-MB-231 cells, fluorescence picture (e) and intensity (g) of MCF-7 cells, fluorescence picture (f) and intensity (h) of A549 cells. A: C6-Sol, B: NLC-C6, C: FA-NLC-C6, D: E-[c(RGDfK)2]-NLC-C6, E: E-[c(RGDfK)2]/FA-NLC-C6. *p < 0.05, **p < 0.01. Results are expressed as mean ± SD, n = 3

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us